Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F, Charabati M, Lee J-H, Kye Y-C, Choi J, Sanmarco LM, Srun L, Chung EN, Flausino LE, Andersen BM, Rothhammer V, Yano H, Illouz T, Zandee SEJ, Daniel C, Artis D, Prinz M, Abate AR, Kuchroo VK, Antel JP, Prat A, Quintana FJ.
Droplet-based forward genetic screening of astrocyte-microglia cross-talk. Science. 2023;379(6636):1023-1030.
Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP, Telesford K, Winokur PN, Rumah KR, Gauthier SA, Fischetti VA, McClane BA, Uzal FA, Zexter L, Mazzucco M, Rudick R, Danko D, Balmuth E, Nealon N, Perumal J, Kaunzner U, Brito IL, Chen Z, Xiang JZ, Betel D, Daneman R, Sonnenberg GF, Mason CE, Vartanian T.
Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege. J Clin Invest. 2023;133(9).
Venturelli OS, Wang HH, Estrela S, Huang KCasey, Ledesma-Amaro R, Fedorec AJH, Stecher B, Lawson CE, Zarrinpar A, Guo C-J, Soyer OS.
What is the key challenge in engineering microbiomes?. Cell Syst. 2023;14(2):85-90.